Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology

被引：2

作者：

He, Liqi ^{[1
]}

Zhang, Meng Yao ^{[1
]}

Cox, Matthew ^{[1
]}

Zhang, Qian ^{[1
]}

Donnell, Andrew F. ^{[2
]}

Zhang, Yong ^{[2
]}

Tarby, Christine ^{[2
]}

Gill, Patrice ^{[2
]}

Subbaiah, Murugaiah A. M. ^{[3
]}

Ramar, Thangeswaran ^{[3
]}

Reddy, Maheswara ^{[3
]}

Puttapaka, Vijaya ^{[3
]}

Li, Yi-Xin ^{[1
]}

Sivaprakasam, Prasanna ^{[2
]}

Critton, David ^{[2
]}

Mulligan, Dawn ^{[2
]}

Xie, Chunshan ^{[2
]}

Ramakrishnan, Radha ^{[2
]}

Nagar, Jignesh ^{[3
]}

Dudhgaonkar, Shailesh ^{[3
]}

Murtaza, Anwar ^{[2
]}

Oderinde, Martins S. ^{[2
]}

Schieven, Gary L. ^{[2
]}

Mathur, Arvind ^{[2
]}

Gavai, Ashvinikumar V. ^{[2
]}

Vite, Gregory ^{[2
]}

Gangwar, Sanjeev ^{[1
]}

Poudel, Yam B. ^{[1
]}

机构：

[1] Bristol Myers Squibb, Res & Dev, Redwood City, CA 94063 USA

[2] Bristol Myers Squibb, Res & Dev, Princeton, NJ 08543 USA

[3] Biocon Bristol Myers Squibb R&D Ctr, Bangalore 560099, India

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 02期

关键词：

TLR7; agonist; Tumor; Immuno-oncology; Cancer; PD1;

D O I：

10.1021/acsmedchemlett.3c00456

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Small molecule toll-like receptor (TLR) 7 agonists have gathered considerable interest as promising therapeutic agents for applications in cancer immunotherapy. Herein, we describe the development and optimization of a series of novel TLR7 agonists through systematic structure-activity relationship studies focusing on modification of the phenylpiperidine side chain. Additional refinement of ADME properties culminated in the discovery of compound 14, which displayed nanomolar reporter assay activity and favorable drug-like properties. Compound 14 demonstrated excellent in vivo pharmacokinetic/pharmacodynamic profiles and synergistic antitumor activity when administered in combination with aPD1 antibody, suggesting opportunities of employing 14 in immuno-oncology therapies with immune checkpoint blockade agents.

引用

页码：189 / 196

页数：8

共 48 条

[31] Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation
Diao, Yuwen
Wang, Xiaodong
Wan, Yanyan
Zhong, Jingjing
Gao, Dong
Liu, Yu
Gao, Ningning
Li, Wang
Liu, Bing
Huang, Xinping
Jin, Zhenchao
Peng, Boya
Wang, Zhulin
Fu, Li
Chen, Siping
Jin, Guangyi
ONCOLOGY REPORTS, 2016, 35 (02) : 793 - 800
[32] Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)
Mussari, Christopher P.
Dodd, Dharmpal S.
Sreekantha, Ratna Kumar
Pasunoori, Laxman
Wan, Honghe
Posy, Shana L.
Critton, David
Ruepp, Stefan
Subramanian, Murali
Watson, Andrew
Davies, Paul
Schieven, Gary L.
Salter-Cid, Luisa M.
Srivastava, Ratika
Tagore, Debarati Mazumder
Dudhgaonkar, Shailesh
Poss, Michael A.
Carter, Percy H.
Dyckman, Alaric J.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1751 - 1758
[33] A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology
Burgess, Teresa L.
Amason, Joshua D.
Rubin, Jeffrey S.
Duveau, Damien Y.
Lamy, Laurence
Roberts, David D.
Farrell, Catherine L.
Inglese, James
Thomas, Craig J.
Miller, Thomas W.
PLOS ONE, 2020, 15 (04):
[34] Preclinical mechanistic and efficacy evaluation of a novel small molecule TLR7 agonist RO7020531 for the treatment of chronic hepatitis B
Dai, L.
Yu, X.
Yu, Y.
Gu, L.
Zhao, J.
Zhu, L.
Ottaviani, G.
Yun, H.
Ait-Goughoulte, M.
Ilnicka, M.
Xie, J.
Wang, L.
Feng, A.
Young, J.
Gao, L.
JOURNAL OF HEPATOLOGY, 2018, 68 : S802 - S803
[35] Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
Xiao, Jingbo
Huang, Zaohua
Chen, Catherine Z.
Agoulnik, Irina U.
Southall, Noel
Hu, Xin
Jones, Raisa E.
Ferrer, Marc
Zheng, Wei
Agoulnik, Alexander I.
Marugan, Juan J.
NATURE COMMUNICATIONS, 2013, 4
[36] Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
Jingbo Xiao
Zaohua Huang
Catherine Z. Chen
Irina U. Agoulnik
Noel Southall
Xin Hu
Raisa E. Jones
Marc Ferrer
Wei Zheng
Alexander I. Agoulnik
Juan J. Marugan
Nature Communications, 4
[37] Novel small-molecule RORc agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial
Wang, J.
Liu, S. V.
Uronis, H. E.
Wu, C.
Mahalingam, D.
Spira, A.
Carter, L.
Hu, X.
Weems, G.
Wilkins, H. J.
Duska, L. R.
Kelly, K.
ANNALS OF ONCOLOGY, 2018, 29
[38] Identification of new IL-7Rα small-molecule agonists: a multi-computational approach
Lee, J-Y
Lee, K.
Koh, B.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2021, 32 (09) : 719 - 729
[39] Rapid identification and optimization of small molecule agonists and antagonists for novel targets: General considerations and specific examples.
Shaw, KR
Hutchison, AJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U593 - U593
[40] Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating aSynthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles onImmunostimulatory Effects
Shinchi, Hiroyuki
Komaki, Fumikazu
Yuki, Masaharu
Ohara, Haruka
Hayakawa, Naohiro
Wakao, Masahiro
Cottam, Howard B.
Hayashi, Tomoko
Carson, Dennis A.
Moroishi, Toshiro
Suda, Yasuo
ACS CHEMICAL BIOLOGY, 2022, 17 (04) : 957 - 968

← 1 2 3 4 5 →